{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T01:21:22Z","timestamp":1794792082106,"version":"4.9.1"},"reference-count":172,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,11,13]],"date-time":"2027-11-13T00:00:00Z","timestamp":1826064000000},"content-version":"am","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006521","name":"School of Medicine, Stanford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA124435"],"award-info":[{"award-number":["P30CA124435"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA262106"],"award-info":[{"award-number":["R01CA262106"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["PHY-1935762"],"award-info":[{"award-number":["PHY-1935762"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.medj.2026.101326","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:22:55Z","timestamp":1791904975000},"page":"101326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cancer plasticity and histological transformation as adaptive resistance mechanisms in precision oncology"],"prefix":"10.1016","volume":"7","author":[{"given":"Nick A.","family":"Kuburich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Gouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Breanna R.","family":"Demestichas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preetesh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"den Hollander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny","family":"Yakirevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razelle","family":"Kurzrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafik S.","family":"El-Deiry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sendurai A.","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6064-6837","authenticated-orcid":false,"given":"Vivek","family":"Subbiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2026.101326_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.medj.2026.101326_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.medj.2026.101326_bib3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","article-title":"The Different Mechanisms of Cancer Drug Resistance: A Brief Review","volume":"7","author":"Mansoori","year":"2017","journal-title":"Adv. Pharmaceut. Bull."},{"key":"10.1016\/j.medj.2026.101326_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cllc.2017.05.019","article-title":"An Evolving Algorithm to Select and Sequence Therapies in EGFR Mutation-positive NSCLC: A Strategic Approach","volume":"19","author":"Melosky","year":"2018","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.medj.2026.101326_bib5","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1158\/2159-8290.CD-24-1866","article-title":"Histologic Transformation in Cancer: The Path for Clinical Translation","volume":"15","author":"Vathiotis","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.medj.2026.101326_bib6","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41422-025-01180-x","article-title":"Lineage plasticity and histological transformation: tumor histology as a spectrum","volume":"35","author":"Li","year":"2025","journal-title":"Cell Res."},{"key":"10.1016\/j.medj.2026.101326_bib7","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.jtho.2025.06.012","article-title":"Molecular Landscape and Therapeutic Strategies of Lung Cancer Lineage Plasticity","volume":"20","author":"Banerjee","year":"2025","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib8","article-title":"Targeting mutant EGFR in non-small cell lung cancer in the context of cell adaptation and resistance","volume":"30","author":"Roberts","year":"2025","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.medj.2026.101326_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002003","article-title":"Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors","volume":"3","author":"Sequist","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.medj.2026.101326_bib10","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1158\/0008-5472.CAN-21-0556","article-title":"Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, Osimertinib","volume":"81","author":"Zhu","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.medj.2026.101326_bib11","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221130503","article-title":"Histologic transformation in lung cancer: when one door shuts, another opens","volume":"14","author":"Sato","year":"2022","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib12","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.medj.2026.101326_bib13","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-026-16114-y","article-title":"Histological transformation in lung cancer: a single-arm meta-analysis and systematic review","volume":"26","author":"Hu","year":"2026","journal-title":"BMC Cancer"},{"key":"10.1016\/j.medj.2026.101326_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.105326","article-title":"Correlation between treatments and outcomes of patients with EGFR-mutated non-small-cell lung cancer that transitioned into small-cell lung cancer: an international retrospective study","volume":"10","author":"Catania","year":"2025","journal-title":"ESMO Open"},{"key":"10.1016\/j.medj.2026.101326_bib15","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.21037\/jtd-23-161","article-title":"Expression of EGFR-mutant proteins and genomic evolution in EGFR-mutant transformed small cell lung cancer","volume":"15","author":"Zhang","year":"2023","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.medj.2026.101326_bib16","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1158\/1078-0432.CCR-24-0160","article-title":"Transcriptomic Heterogeneity of EGFR-Mutant Non-Small Cell Lung Cancer Evolution Toward Small-Cell Lung Cancer","volume":"30","author":"Oh","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.medj.2026.101326_bib17","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/annonc\/mdv611","article-title":"Changes in tumor expression of HER2 and hormone receptors status after neoadjuvant chemotherapy in 21,755 patients from the Japanese breast cancer registry","volume":"27","author":"Niikura","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejca.2016.03.006","article-title":"Effect of neoadjuvant chemotherapy on breast cancer phenotype, ER\/PR and HER2 expression - Implications for the practising oncologist","volume":"60","author":"Gahlaut","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.medj.2026.101326_bib19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10555-016-9631-3","article-title":"Estrogen, progesterone, and HER2\/neu receptor discordance between primary and metastatic breast tumours-a review","volume":"35","author":"Yeung","year":"2016","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.medj.2026.101326_bib20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejca.2013.10.004","article-title":"A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases","volume":"50","author":"Aurilio","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.medj.2026.101326_bib21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10549-019-05173-4","article-title":"Loss of HER2 after HER2-targeted treatment","volume":"175","author":"Ignatov","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.medj.2026.101326_bib22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10120-018-0891-1","article-title":"Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: results of the GASTric cancer HER2 reassessment study 3 (GASTHER3)","volume":"22","author":"Seo","year":"2019","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.medj.2026.101326_bib23","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1038\/s43018-024-00817-x","article-title":"A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependencies","volume":"5","author":"Li","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.medj.2026.101326_bib24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41571-022-00696-0","article-title":"Neuroendocrine neoplasms of the lung and gastrointestinal system: convergent biology and a path to better therapies","volume":"20","author":"Kawasaki","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib25","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1210\/me.2003-0031","article-title":"Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells","volume":"17","author":"Wright","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.medj.2026.101326_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.aah4199","article-title":"Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance","volume":"355","author":"Ku","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.medj.2026.101326_bib27","article-title":"Brief Report: Comprehensive clinicogenomic profiling of small cell transformation from EGFR-mutant non-small cell lung cancer informs potential therapeutic targets","volume":"5","author":"Zhang","year":"2024","journal-title":"JTO Clin. Res. Rep."},{"key":"10.1016\/j.medj.2026.101326_bib28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cllc.2022.10.005","article-title":"Small-Cell Lung Cancer Transformation as a Mechanism of Resistance to Pralsetinib in RET-Rearranged Lung Adenocarcinoma: A Case Report","volume":"24","author":"Gazeu","year":"2023","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.medj.2026.101326_bib35","article-title":"Histomorphological transformation from non-small cell lung carcinoma to small cell lung carcinoma after targeted therapy or immunotherapy: A report of two cases","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMc053610","article-title":"EGFR mutations in small-cell lung cancers in patients who have never smoked","volume":"355","author":"Zakowski","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2026.101326_bib37","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/pin.12919","article-title":"Transformation from EGFR\/PTEN co-mutated lung adenocarcinoma to small cell carcinoma in lymph node metastasis","volume":"70","author":"Hayashi","year":"2020","journal-title":"Pathol. Int."},{"key":"10.1016\/j.medj.2026.101326_bib38","first-page":"52","article-title":"Small cell lung cancer transformation during immunotherapy with nivolumab: A case report","volume":"21","author":"Imakita","year":"2017","journal-title":"Respir. Med. Case Rep."},{"key":"10.1016\/j.medj.2026.101326_bib39","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/1759-7714.13312","article-title":"Histologic transformation of lung cancer during pembrolizumab therapy: A case report","volume":"11","author":"Si","year":"2020","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.medj.2026.101326_bib40","article-title":"Case Report: Transformation From Non-Small Cell Lung Cancer to Small Cell Lung Cancer During Anti-PD-1 Therapy: A Report of Two Cases","volume":"11","author":"Shen","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib29","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.humpath.2017.01.006","article-title":"Transformation of prostatic adenocarcinoma to well-differentiated neuroendocrine tumor after hormonal treatment","volume":"64","author":"Gilani","year":"2017","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.medj.2026.101326_bib41","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1200\/JCO.2017.77.6880","article-title":"Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study","volume":"36","author":"Aggarwal","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib42","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1046\/j.1464-4096.2001.00936.x","article-title":"Neuroendocrine differentiated small cell carcinoma presenting as recurrent prostate cancer after androgen deprivation therapy","volume":"88","author":"Miyoshi","year":"2001","journal-title":"BJU Int."},{"key":"10.1016\/j.medj.2026.101326_bib43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejca.2019.08.011","article-title":"Clinical features of neuroendocrine prostate cancer","volume":"121","author":"Conteduca","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.medj.2026.101326_bib44","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a030593","article-title":"Neuroendocrine Differentiation in Prostate Cancer: Emerging Biology, Models, and Therapies","volume":"9","author":"Puca","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.medj.2026.101326_bib45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/cai2.57","article-title":"Large cell neuroendocrine carcinoma transformation: A novel acquired drug resistance mechanism in colorectal adenocarcinoma","volume":"2","author":"Du","year":"2023","journal-title":"Cancer Innov."},{"key":"10.1016\/j.medj.2026.101326_bib30","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1016\/j.cllc.2017.10.005","article-title":"Squamous Cell Carcinoma Transformation from EGFR-mutated Lung Adenocarcinoma: A Case Report and Literature Review","volume":"19","author":"Izumi","year":"2018","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.medj.2026.101326_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41698-023-00398-5","article-title":"Histological transformation to gliosarcoma with combined BRAF\/MEK inhibition in BRAF V600E mutated glioblastoma","volume":"7","author":"Nelson","year":"2023","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib32","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1016\/j.clml.2021.10.017","article-title":"Chronic Lymphocytic Leukemia\/Small Lymphocytic Lymphoma With Secondary Acquisition of t(11;14)(q13;q32)\/CCND1-IGH: A Rare Variant Of Richter Transformation to Mantle Cell Lymphoma","volume":"22","author":"Zhao","year":"2022","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.medj.2026.101326_bib33","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s12185-016-2018-y","article-title":"Classical Hodgkin lymphoma primary refractory to brentuximab vedotin, with transformation to CD30-positive diffuse large B-cell lymphoma","volume":"104","author":"Makita","year":"2016","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.medj.2026.101326_bib34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/ajcp\/aqac087","article-title":"Histiocytic Sarcoma With CCND1 Gene Rearrangement Clonally Related and Transdifferentiated From Mantle Cell Lymphoma","volume":"158","author":"Kumar","year":"2022","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.medj.2026.101326_bib46","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1158\/2159-8290.CD-20-1863","article-title":"Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine Transformation","volume":"11","author":"Quintanal-Villalonga","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.medj.2026.101326_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/science.adj1415","article-title":"Lineage-specific intolerance to oncogenic drivers restricts histological transformation","volume":"383","author":"Gardner","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.medj.2026.101326_bib48","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1158\/1078-0432.CCR-22-3743","article-title":"Immunogenomic Landscape of Neuroendocrine Prostate Cancer","volume":"29","author":"Bhinder","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.medj.2026.101326_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102606","article-title":"Shaping the tumor immune microenvironment of SCLC: Mechanisms, and opportunities for immunotherapy","volume":"120","author":"Chen","year":"2023","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.medj.2026.101326_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.189007","article-title":"The association between the neuroendocrine system and the tumor immune microenvironment: Emerging directions for cancer immunotherapy","volume":"1878","author":"Li","year":"2023","journal-title":"Biochim. Biophys. Acta. Rev. Cancer"},{"key":"10.1016\/j.medj.2026.101326_bib51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbcan.2018.06.006","article-title":"EMT, stemness and tumor plasticity in aggressive variant neuroendocrine prostate cancers","volume":"1870","author":"Soundararajan","year":"2018","journal-title":"Biochim. Biophys. Acta. Rev. Cancer"},{"key":"10.1016\/j.medj.2026.101326_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113448","article-title":"Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment","volume":"12","author":"Busse","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.medj.2026.101326_bib53","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fonc.2019.00343","article-title":"PD-L1 Expression and Immune Cell Infiltration in Gastroenteropancreatic (GEP) and Non-GEP Neuroendocrine Neoplasms With High Proliferative Activity","volume":"9","author":"Ferrata","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib54","article-title":"Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunities","volume":"5","author":"Desai","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.medj.2026.101326_bib55","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.celrep.2015.07.012","article-title":"The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer","volume":"12","author":"Akamatsu","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.medj.2026.101326_bib56","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aah4307","article-title":"SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer","volume":"355","author":"Mu","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.medj.2026.101326_bib57","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2159-8290.CD-15-1263","article-title":"The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer","volume":"7","author":"Bishop","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.medj.2026.101326_bib58","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1038\/onc.2017.50","article-title":"FOXA1 inhibits prostate cancer neuroendocrine differentiation","volume":"36","author":"Kim","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.medj.2026.101326_bib59","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.humpath.2016.06.004","article-title":"Androgen deprivation modulates gene expression profile along prostate cancer progression","volume":"56","author":"Volante","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.medj.2026.101326_bib60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.semcancer.2022.05.007","article-title":"Molecular mechanisms underlying the development of neuroendocrine prostate cancer","volume":"86","author":"Liu","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.medj.2026.101326_bib61","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1158\/2159-8290.CD-16-1174","article-title":"Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer","volume":"7","author":"Zou","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.medj.2026.101326_bib62","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1158\/2159-8290.CD-17-0481","article-title":"The Path of Most Resistance: Transdifferentiation Underlies Exceptional Nonresponses to Androgen Receptor Pathway Inhibition in Prostate Cancer","volume":"7","author":"Sinha","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.medj.2026.101326_bib63","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1038\/s41588-025-02265-4","article-title":"NKX2-1 drives neuroendocrine transdifferentiation of prostate cancer via epigenetic and 3D chromatin remodeling","volume":"57","author":"Lu","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.medj.2026.101326_bib64","article-title":"CXCR4-LASP1-G9a-SNAIL axis drives NEPC transdifferentiation via induction of EMT and downregulation of REST","volume":"5","author":"Liu","year":"2025","journal-title":"Cell Genom."},{"key":"10.1016\/j.medj.2026.101326_bib65","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41568-019-0133-9","article-title":"Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data","volume":"19","author":"Rudin","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.medj.2026.101326_bib66","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1097\/JTO.0000000000000571","article-title":"Histologic Transformation from Adenocarcinoma to Squamous Cell Carcinoma as a Mechanism of Resistance to EGFR Inhibition","volume":"10","author":"Levin","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/rcr2.521","article-title":"Squamous cell transformation as a mechanism of acquired resistance to tyrosine kinase inhibitor in EGFR-mutated lung adenocarcinoma: a report of two cases","volume":"8","author":"Uruga","year":"2020","journal-title":"Respirol. Case Rep."},{"key":"10.1016\/j.medj.2026.101326_bib68","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1158\/1078-0432.CCR-19-3563","article-title":"Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung Cancer","volume":"26","author":"Schoenfeld","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.medj.2026.101326_bib69","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13045-021-01186-z","article-title":"Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation","volume":"14","author":"Quintanal-Villalonga","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib70","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aea4881","article-title":"Clinicogenomic analysis of EGFR-mutant lung tumors identifies Rb pathway inactivation as a hallmark of squamous transformation","volume":"18","author":"Dymun","year":"2026","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.medj.2026.101326_bib71","article-title":"Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.medj.2026.101326_bib72","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nature06030","article-title":"LKB1 modulates lung cancer differentiation and metastasis","volume":"448","author":"Ji","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.medj.2026.101326_bib73","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ccell.2024.01.012","article-title":"Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer","volume":"42","author":"Tong","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.medj.2026.101326_bib74","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.lungcan.2019.05.024","article-title":"Paired genomic analysis of squamous cell carcinoma transformed from EGFR-mutated lung adenocarcinoma","volume":"134","author":"Park","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.medj.2026.101326_bib75","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ajpath.2017.01.009","article-title":"Evidence, Mechanism, and Clinical Relevance of the Transdifferentiation from Lung Adenocarcinoma to Squamous Cell Carcinoma","volume":"187","author":"Hou","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.medj.2026.101326_bib76","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s43018-019-0010-1","article-title":"A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma","volume":"1","author":"Hayashi","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.medj.2026.101326_bib77","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41571-020-0340-z","article-title":"Lineage plasticity in cancer: a shared pathway of therapeutic resistance","volume":"17","author":"Quintanal-Villalonga","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib78","doi-asserted-by":"crossref","first-page":"345","DOI":"10.14744\/cpr.2025.44690","article-title":"Epithelial-Mesenchymal Transition as a Pathogenetic Mechanism of Sarcomatoid Carcinoma and Carcinosarcoma","volume":"47","author":"Guarino","year":"2025","journal-title":"J. Clin. Pract. Res."},{"key":"10.1016\/j.medj.2026.101326_bib79","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41586-020-03046-1","article-title":"Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis","volume":"589","author":"Pastushenko","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.medj.2026.101326_bib80","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fonc.2015.00155","article-title":"Implications of the Hybrid Epithelial\/Mesenchymal Phenotype in Metastasis","volume":"5","author":"Jolly","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib81","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pharmthera.2018.09.007","article-title":"Hybrid epithelial\/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas","volume":"194","author":"Jolly","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.medj.2026.101326_bib82","doi-asserted-by":"crossref","first-page":"27067","DOI":"10.18632\/oncotarget.8166","article-title":"Stability of the hybrid epithelial\/mesenchymal phenotype","volume":"7","author":"Jolly","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.medj.2026.101326_bib83","first-page":"75","article-title":"Rare transformation from lung adenocarcinoma to sarcomatoid carcinoma mediates resistance to inhibitors targeting different driver oncogenes","volume":"5","author":"Pang","year":"2025","journal-title":"J. Natl. Cancer Cent."},{"key":"10.1016\/j.medj.2026.101326_bib84","article-title":"Treatment strategies for rapid recurrence and progression after surgery for stage I pulmonary pleomorphic carcinoma: a case report and literature review","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.medj.2026.101326_bib85","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.celrep.2019.04.048","article-title":"Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer","volume":"27","author":"Guo","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.medj.2026.101326_bib86","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ncb2173","article-title":"p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs","volume":"13","author":"Chang","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.medj.2026.101326_bib87","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncb1722","article-title":"The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1","volume":"10","author":"Gregory","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.medj.2026.101326_bib88","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.20110235","article-title":"p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2","volume":"208","author":"Kim","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.medj.2026.101326_bib89","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1101\/gad.1640608","article-title":"The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2","volume":"22","author":"Park","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.medj.2026.101326_bib90","article-title":"Sarcomatoid carcinoma transformation in oral undifferentiated carcinoma following sequential immune combined targeted therapy: a case report","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.medj.2026.101326_bib91","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s00432-022-04022-0","article-title":"Transformation of invasive lung adenocarcinoma with ALK rearrangement into pulmonary sarcomatoid carcinoma","volume":"148","author":"Xie","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib92","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1097\/JTO.0b013e318293d96f","article-title":"Transformation to Sarcomatoid Carcinoma in ALK-Rearranged Adenocarcinoma, Which Developed Acquired Resistance to Crizotinib and Received Subsequent Chemotherapies","volume":"8","author":"Kobayashi","year":"2013","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib93","doi-asserted-by":"crossref","DOI":"10.1177\/17588359241236450","article-title":"Histological sarcomatoid transformation in a lung adenocarcinoma patient following immune checkpoint blockade","volume":"16","author":"Liang","year":"2024","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib94","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ccr.2007.11.004","article-title":"Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition","volume":"12","author":"Acevedo","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.medj.2026.101326_bib95","doi-asserted-by":"crossref","DOI":"10.3171\/CASE2099","article-title":"A case of brain metastasis with pathological transformation of long-surviving malignant pleural mesothelioma: illustrative case","volume":"1","author":"Noda","year":"2021","journal-title":"J. Neurosurg. Case Lessons"},{"key":"10.1016\/j.medj.2026.101326_bib96","doi-asserted-by":"crossref","first-page":"e536","DOI":"10.1016\/j.cllc.2020.06.026","article-title":"Transformations First Into Squamous-Cell Carcinoma and Later Into Sarcomatoid Carcinoma After Acquired Resistance to Osimertinib in a Patient With EGFR-Mutant Lung Adenocarcinoma: Case Report","volume":"22","author":"Lee","year":"2021","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.medj.2026.101326_bib97","article-title":"Heterogeneity of resistant mechanisms in an EGFR-TKI relapsed patient with EGFR amplification and response to nimotuzumab: A case report","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2024.104909","article-title":"Epithelial-mesenchymal transition associated markers in sarcomatoid transformation of clear cell renal cell carcinoma","volume":"138","author":"\u010cugura","year":"2024","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.medj.2026.101326_bib99","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.humpath.2011.06.019","article-title":"Sarcomatoid conversion of clear cell renal cell carcinoma in relation to epithelial-to-mesenchymal transition","volume":"43","author":"Bostr\u00f6m","year":"2012","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.medj.2026.101326_bib100","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.1002\/cam4.4162","article-title":"Sarcomatoid hepatocellular carcinoma: From clinical features to cancer genome","volume":"10","author":"Zhang","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.medj.2026.101326_bib101","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/modpathol.2011.167","article-title":"Metaplastic breast carcinomas are enriched in markers of tumor-initiating cells and epithelial to mesenchymal transition","volume":"25","author":"Zhang","year":"2012","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.medj.2026.101326_bib102","doi-asserted-by":"crossref","first-page":"543","DOI":"10.5858\/arpa.2015-0085-OA","article-title":"Sarcomatoid Urothelial Carcinoma of the Bladder: Analysis of 28 Cases With Emphasis on Clinicopathologic Features and Markers of Epithelial-to-Mesenchymal Transition","volume":"140","author":"Sanfrancesco","year":"2016","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.medj.2026.101326_bib103","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jtho.2024.04.019","article-title":"Tracing Tumor Heterogeneity of Pleomorphic Carcinoma of the Lung","volume":"19","author":"Roma","year":"2024","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib104","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1038\/s42003-025-09162-w","article-title":"Single-cell and spatial transcriptomic characterization of pulmonary pleomorphic carcinoma","volume":"8","author":"Matsuoka","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.medj.2026.101326_bib105","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1200\/JCO.2015.62.0674","article-title":"Next-Generation Sequencing of Pulmonary Sarcomatoid Carcinoma Reveals High Frequency of Actionable MET Gene Mutations","volume":"34","author":"Liu","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib106","first-page":"5379","article-title":"Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors","volume":"57","author":"Wada","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.medj.2026.101326_bib107","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1182\/blood-2010-09-302174","article-title":"The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation","volume":"117","author":"Rossi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.medj.2026.101326_bib108","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1182\/blood-2018-01-791376","article-title":"Biology and treatment of Richter syndrome","volume":"131","author":"Rossi","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.medj.2026.101326_bib109","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/PAS.0b013e31804bdaf8","article-title":"IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution","volume":"31","author":"Mao","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.medj.2026.101326_bib110","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00277-017-3218-0","article-title":"The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database","volume":"97","author":"Janikova","year":"2018","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.medj.2026.101326_bib111","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1349-7006.2008.01005.x","article-title":"Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy","volume":"100","author":"Maeshima","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.medj.2026.101326_bib112","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/bjh.12458","article-title":"Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients","volume":"162","author":"Parikh","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.medj.2026.101326_bib113","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1084\/jem.20131448","article-title":"Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome","volume":"210","author":"Fabbri","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.medj.2026.101326_bib114","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/hon.2502","article-title":"Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia","volume":"36","author":"Innocenti","year":"2018","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib115","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1182\/blood-2016-06-719294","article-title":"Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia","volume":"129","author":"Ahn","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.medj.2026.101326_bib116","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/s41591-022-01927-8","article-title":"Detection of early seeding of Richter transformation in chronic lymphocytic leukemia","volume":"28","author":"Nadeu","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2026.101326_bib117","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s41571-025-01058-2","article-title":"EMT and cancer: what clinicians should know","volume":"22","author":"Thompson","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib118","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41576-023-00601-0","article-title":"The epithelial-mesenchymal plasticity landscape: principles of design and mechanisms of regulation","volume":"24","author":"Haerinck","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.medj.2026.101326_bib119","doi-asserted-by":"crossref","DOI":"10.3390\/biom12030348","article-title":"Population Dynamics of Epithelial-Mesenchymal Heterogeneity in Cancer Cells","volume":"12","author":"Jain","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.medj.2026.101326_bib120","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrc.2017.118","article-title":"EMT in cancer","volume":"18","author":"Brabletz","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.medj.2026.101326_bib121","doi-asserted-by":"crossref","first-page":"6330","DOI":"10.1158\/0008-5472.CAN-14-0923","article-title":"Transient SNAIL1 expression is necessary for metastatic competence in breast cancer","volume":"74","author":"Tran","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.medj.2026.101326_bib122","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/ncb3513","article-title":"The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer","volume":"19","author":"Krebs","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.medj.2026.101326_bib123","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/stem.467","article-title":"Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells","volume":"28","author":"Battula","year":"2010","journal-title":"Stem Cell."},{"key":"10.1016\/j.medj.2026.101326_bib124","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.ccell.2021.05.005","article-title":"Single-cell lineage tracing of metastatic cancer reveals selection of hybrid EMT states","volume":"39","author":"Simeonov","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.medj.2026.101326_bib125","doi-asserted-by":"crossref","first-page":"13820","DOI":"10.1073\/pnas.0905718106","article-title":"Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features","volume":"106","author":"Creighton","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.medj.2026.101326_bib126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2021.10.006","article-title":"Polyploid giant cancer cells: An emerging new field of cancer biology","volume":"81","author":"Liu","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.medj.2026.101326_bib127","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/onc.2013.96","article-title":"Generation of cancer stem-like cells through the formation of polyploid giant cancer cells","volume":"33","author":"Zhang","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.medj.2026.101326_bib128","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.stem.2019.07.002","article-title":"Defining Adult Stem Cell Function at Its Simplest: The Ability to Replace Lost Cells through Mitosis","volume":"25","author":"Post","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.medj.2026.101326_bib129","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.cell.2012.02.008","article-title":"Slug and Sox9 cooperatively determine the mammary stem cell state","volume":"148","author":"Guo","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.medj.2026.101326_bib130","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.medj.2026.101326_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110116","article-title":"Increased prevalence of hybrid epithelial\/mesenchymal state and enhanced phenotypic heterogeneity in basal breast cancer","volume":"27","author":"Sahoo","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.medj.2026.101326_bib132","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ncb1530","article-title":"Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation","volume":"9","author":"Asselin-Labat","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.medj.2026.101326_bib133","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1038\/sj.onc.1210132","article-title":"E-cadherin repression contributes to c-Myc-induced epithelial cell transformation","volume":"26","author":"Cowling","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.medj.2026.101326_bib134","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/onc.2008.395","article-title":"A positive role for Myc in TGFbeta-induced Snail transcription and epithelial-to-mesenchymal transition","volume":"28","author":"Smith","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.medj.2026.101326_bib135","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.canlet.2013.03.027","article-title":"SOX2 promotes tumor metastasis by stimulating epithelial-to-mesenchymal transition via regulation of WNT\/beta-catenin signal network","volume":"336","author":"Li","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.medj.2026.101326_bib136","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1158\/0008-5472.CAN-16-0266","article-title":"Metabolic Plasticity as a Determinant of Tumor Growth and Metastasis","volume":"76","author":"Lehu\u00e9d\u00e9","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.medj.2026.101326_bib137","doi-asserted-by":"crossref","first-page":"44","DOI":"10.20892\/j.issn.2095-3941.2019.0210","article-title":"Metabolic reprogramming in triple-negative breast cancer","volume":"17","author":"Wang","year":"2020","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.medj.2026.101326_bib138","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/bjc.2016.152","article-title":"Hallmarks of cancer stem cell metabolism","volume":"114","author":"Sancho","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.medj.2026.101326_bib139","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","article-title":"ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome","volume":"1","author":"Ginestier","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.medj.2026.101326_bib140","doi-asserted-by":"crossref","first-page":"11707","DOI":"10.1073\/pnas.0603806103","article-title":"Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells","volume":"103","author":"Chute","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.medj.2026.101326_bib141","article-title":"Aldehyde Dehydrogenases: Not Just Markers, but Functional Regulators of Stem Cells","volume":"2019","author":"Vassalli","year":"2019","journal-title":"Stem Cell. Int."},{"key":"10.1016\/j.medj.2026.101326_bib142","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.bbalip.2013.03.010","article-title":"The fat side of prostate cancer","volume":"1831","author":"Zadra","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.medj.2026.101326_bib143","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1007\/s11010-023-04861-6","article-title":"Cancer stem cells: advances in the glucose, lipid and amino acid metabolism","volume":"479","author":"Kong","year":"2024","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.medj.2026.101326_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167164","article-title":"Metabolic adaptations in cancer stem cells: A key to therapy resistance","volume":"1870","author":"Masoudi","year":"2024","journal-title":"Biochim. Biophys. Acta. Mol. Basis Dis."},{"key":"10.1016\/j.medj.2026.101326_bib145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00432-019-03080-1","article-title":"Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance","volume":"146","author":"Najafi","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib146","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1038\/emboj.2012.71","article-title":"HIF1alpha induced switch from bivalent to exclusively glycolytic metabolism during ESC-to-EpiSC\/hESC transition","volume":"31","author":"Zhou","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.medj.2026.101326_bib147","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s42255-019-0032-0","article-title":"Metabolic signatures of cancer cells and stem cells","volume":"1","author":"Intlekofer","year":"2019","journal-title":"Nat. Metab."},{"key":"10.1016\/j.medj.2026.101326_bib148","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.stem.2016.08.008","article-title":"Glycolytic Metabolism Plays a Functional Role in Regulating Human Pluripotent Stem Cell State","volume":"19","author":"Gu","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.medj.2026.101326_bib149","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cmet.2015.02.002","article-title":"Glycolysis-mediated changes in acetyl-CoA and histone acetylation control the early differentiation of embryonic stem cells","volume":"21","author":"Moussaieff","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.medj.2026.101326_bib150","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1126\/science.1164097","article-title":"ATP-citrate lyase links cellular metabolism to histone acetylation","volume":"324","author":"Wellen","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.medj.2026.101326_bib151","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature13981","article-title":"Intracellular alpha-ketoglutarate maintains the pluripotency of embryonic stem cells","volume":"518","author":"Carey","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.medj.2026.101326_bib152","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1158\/0008-5472.CAN-24-0400","article-title":"Accumulation of CD38 in Hybrid Epithelial\/Mesenchymal Cells Promotes Immune Remodeling and Metastasis in Breast Cancer","volume":"85","author":"Visal","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.medj.2026.101326_bib153","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.medj.2026.101326_bib154","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41418-024-01295-5","article-title":"Zeb1-controlled metabolic plasticity enables remodeling of chromatin accessibility in the development of neuroendocrine prostate cancer","volume":"31","author":"Wang","year":"2024","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.medj.2026.101326_bib155","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-018-0040-3","article-title":"Identification of the tumour transition states occurring during EMT","volume":"556","author":"Pastushenko","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.medj.2026.101326_bib156","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136995","article-title":"Macrophage Polarization States in the Tumor Microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.medj.2026.101326_bib157","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-Associated Macrophages in Tumor Immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.medj.2026.101326_bib158","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","article-title":"Diversity, Mechanisms, and Significance of Macrophage Plasticity","volume":"15","author":"Locati","year":"2020","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.medj.2026.101326_bib159","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.cell.2023.12.013","article-title":"Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective","volume":"187","author":"Mathur","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.medj.2026.101326_bib160","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.jtho.2019.06.002","article-title":"Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes","volume":"14","author":"Offin","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib161","doi-asserted-by":"crossref","DOI":"10.3390\/curroncol32100554","article-title":"Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase Inhibition","volume":"32","author":"Rock","year":"2025","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib162","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccell.2024.01.001","article-title":"Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes","volume":"42","author":"Heeke","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.medj.2026.101326_bib163","doi-asserted-by":"crossref","DOI":"10.1172\/JCI161858","article-title":"A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer","volume":"132","author":"Zhao","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.medj.2026.101326_bib164","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1470-2045(24)00249-3","article-title":"Imaging with [(89)Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1\/2, first-in-human trial","volume":"25","author":"Tendler","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib165","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1158\/2159-8290.CD-22-1377","article-title":"N-of-1 Trials in Cancer Drug Development","volume":"13","author":"Gouda","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.medj.2026.101326_bib166","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S1470-2045(22)00541-1","article-title":"Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1\/2, open-label, basket trial","volume":"23","author":"Subbiah","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib167","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1200\/JCO.21.02285","article-title":"Basket Trials: Review of Current Practice and Innovations for Future Trials","volume":"40","author":"Hobbs","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.medj.2026.101326_bib168","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adf7006","article-title":"Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers","volume":"15","author":"Quintanal-Villalonga","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.medj.2026.101326_bib169","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41392-024-01908-y","article-title":"CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation","volume":"9","author":"Quintanal-Villalonga","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.medj.2026.101326_bib170","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41586-025-09299-y","article-title":"NSD2 inhibitors rewire chromatin to treat lung and pancreatic cancers","volume":"649","author":"Jeong","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.medj.2026.101326_bib171","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s43018-025-00928-z","article-title":"Targeting the histone reader ZMYND8 inhibits antiandrogen-induced neuroendocrine tumor transdifferentiation of prostate cancer","volume":"6","author":"Wang","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.medj.2026.101326_bib172","doi-asserted-by":"crossref","first-page":"6779","DOI":"10.1038\/s41467-024-51156-5","article-title":"Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes","volume":"15","author":"Venkadakrishnan","year":"2024","journal-title":"Nat. Commun."}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634026003296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634026003296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T01:00:15Z","timestamp":1794790815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634026003296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":172,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2666634026003296"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2026.101326","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer plasticity and histological transformation as adaptive resistance mechanisms in precision oncology","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2026.101326","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101326"}}